Structure of the MADS-box/MEF2 Domain of MEF2A Bound to DNA and Its Implication for Myocardin Recruitment

Journal of Molecular Biology

Volumn 397, Issue 2, 2010, Pages 520-533

  Wu, Yongqing ^a   Dey, Raja ^a   Han, Aidong ^a   Jayathilaka, Nimanthi ^a   Philips, Michael ^a   Ye, Jun ^a   Chen, Lin ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

drug development; MASTR; MEF2; myocardin; transcription co regulator recruitment

Indexed keywords

CABIN1 PROTEIN; DNA; HISTONE DEACETYLASE 9; HYDROLASE; MADS DOMAIN PROTEIN; MYOCARDIN; MYOCYTE ENHANCER FACTOR 2A; MYOCYTE ENHANCER FACTOR 2B; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIMERIZATION; DNA FLANKING REGION; DNA PROTEIN COMPLEX; DNA SEQUENCE; GENE EXPRESSION; HUMAN; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY;

EID: 77649185159     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.01.067     Document Type: Article

References (61)

1. Gossett L.A., Kelvin D.J., Sternberg E.A., and Olson E.N. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell. Biol. 9 (1989) 5022-5033
2. Potthoff M.J., and Olson E.N. MEF2: a central regulator of diverse developmental programs. Development 134 (2007) 4131-4140
3. Dodou E., and Treisman R. The Saccharomyces cerevisiae MADS-box transcription factor Rlm1 is a target for the Mpk1 mitogen-activated protein kinase pathway. Mol. Cell. Biol. 17 (1997) 1848-1859
4. Bour B.A., O'Brien M.A., Lockwood W.L., Goldstein E.S., Bodmer R., Taghert P.H., et al. Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev. 9 (1995) 730-741
5. Lilly B., Zhao B., Ranganayakulu G., Paterson B.M., Schulz R.A., and Olson E.N. Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science 267 (1995) 688-693
6. Ranganayakulu G., Zhao B., Dokidis A., Molkentin J.D., Olson E.N., and Schulz R.A. A series of mutations in the D-MEF2 transcription factor reveal multiple functions in larval and adult myogenesis in Drosophila. Dev. Biol. 171 (1995) 169-181
7. Lovato T.L., Adams M.M., Baker P.W., and Cripps R.M. A molecular mechanism of temperature sensitivity for mutations affecting the Drosophila muscle regulator Myocyte enhancer factor-2. Genetics 183 (2009) 107-117
8. Sandmann T., Jensen L.J., Jakobsen J.S., Karzynski M.M., Eichenlaub M.P., Bork P., and Furlong E.E. A temporal map of transcription factor activity: Mef2 directly regulates target genes at all stages of muscle development. Dev. Cell 10 (2006) 797-807
9. 2+-induced release of the transcription factor MEF2. Science 286 (1999) 790-793
10. Youn H.D., and Liu J.O. Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity 13 (2000) 85-94
11. Youn H.D., Grozinger C.M., and Liu J.O. Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. J. Biol. Chem. 275 (2000) 22563-22567
12. Pan F., Ye Z., Cheng L., and Liu J.O. Myocyte enhancer factor 2 mediates calcium-dependent transcription of the interleukin-2 gene in T lymphocytes: a calcium signaling module that is distinct from but collaborates with the nuclear factor of activated T cells (NFAT). J. Biol. Chem. 279 (2004) 14477-14480
13. Mao Z., Bonni A., Xia F., Nadal-Vicens M., and Greenberg M.E. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286 (1999) 785-790
14. Chin E.R., Olson E.N., Richardson J.A., Yang Q., Humphries C., Shelton J.M., et al. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 12 (1998) 2499-2509
15. Wu H., Naya F.J., McKinsey T.A., Mercer B., Shelton J.M., Chin E.R., et al. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J. 19 (2000) 1963-1973
16. Kim Y., Phan D., van Rooij E., Wang D.Z., McAnally J., Qi X., et al. The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J. Clin. Invest. 118 (2008) 124-132
17. Flavell S.W., Cowan C.W., Kim T.K., Greer P.L., Lin Y., Paradis S., et al. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311 (2006) 1008-1012
18. Shalizi A., Gaudilliere B., Yuan Z., Stegmuller J., Shirogane T., Ge Q., et al. A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 311 (2006) 1012-1017
19. Yang Q., She H., Gearing M., Colla E., Lee M., Shacka J.J., and Mao Z. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science 323 (2009) 124-127
20. Wu H., Rothermel B., Kanatous S., Rosenberg P., Naya F.J., Shelton J.M., et al. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J. 20 (2001) 6414-6423
21. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., and Olson E.N. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110 (2002) 479-488
22. Wei J.Q., Shehadeh L.A., Mitrani J.M., Pessanha M., Slepak T.I., Webster K.A., and Bishopric N.H. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Circulation 118 (2008) 934-946
23. Tao R., de Zoeten E.F., Ozkaynak E., Chen C., Wang L., Porrett P.M., et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13 (2007) 1299-1307
24. Flavell S.W., Kim T.K., Gray J.M., Harmin D.A., Hemberg M., Hong E.J., et al. Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron 60 (2008) 1022-1038
25. Pulipparacharuvil S., Renthal W., Hale C.F., Taniguchi M., Xiao G., Kumar A., et al. Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron 59 (2008) 621-633
26. Lund A.H., Turner G., Trubetskoy A., Verhoeven E., Wientjens E., Hulsman D., et al. Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice. Nat. Genet. 32 (2002) 160-165
27. Suzuki T., Shen H., Akagi K., Morse H.C., Malley J.D., Naiman D.Q., et al. New genes involved in cancer identified by retroviral tagging. Nat. Genet. 32 (2002) 166-174
28. Krivtsov A.V., Twomey D., Feng Z., Stubbs M.C., Wang Y., Faber J., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442 (2006) 818-822
29. Yuki Y., Imoto I., Imaizumi M., Hibi S., Kaneko Y., Amagasa T., and Inazawa J. Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13). Cancer Sci. 95 (2004) 503-507
30. Prima V., Gore L., Caires A., Boomer T., Yoshinari M., Imaizumi M., et al. Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia. Leukemia 19 (2005) 806-813
31. Shore P., and Sharrocks A.D. The MADS-box family of transcription factors. Eur. J. Biochem. 229 (1995) 1-13
32. Andres V., Cervera M., and Mahdavi V. Determination of the consensus binding site for MEF2 expressed in muscle and brain reveals tissue-specific sequence constraints. J. Biol. Chem. 270 (1995) 23246-23249
33. Fickett J.W. Quantitative discrimination of MEF2 sites. Mol. Cell. Biol. 16 (1996) 437-441
34. Yu Y.T., Breitbart R.E., Smoot L.B., Lee Y., Mahdavi V., and Nadal-Ginard B. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev. 6 (1992) 1783-1798
35. Kato Y., Kravchenko V.V., Tapping R.I., Han J., Ulevitch R.J., and Lee J.D. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16 (1997) 7054-7066
36. Molkentin J.D., and Olson E.N. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl Acad. Sci. USA 93 (1996) 9366-9373
37. Quinn Z.A., Yang C.C., Wrana J.L., and McDermott J.C. Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. Nucleic Acids Res. 29 (2001) 732-742
38. Bertos N.R., Wang A.H., and Yang X.J. Class II histone deacetylases: structure, function, and regulation. Biochem. Cell Biol. 79 (2001) 243-252
39. Gregoire S., Xiao L., Nie J., Zhang X., Xu M., Li J., et al. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol. Cell. Biol. 27 (2007) 1280-1295
40. Miska E.A., Karlsson C., Langley E., Nielsen S.J., Pines J., and Kouzarides T. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18 (1999) 5099-5107
41. Sparrow D.B., Miska E.A., Langley E., Reynaud-Deonauth S., Kotecha S., Towers N., et al. MEF-2 function is modified by a novel co-repressor, MITR. EMBO J. 18 (1999) 5085-5098
42. McKinsey T.A., Zhang C.L., and Olson E.N. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev 11 (2001) 497-504
43. Sartorelli V., Huang J., Hamamori Y., and Kedes L. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17 (1997) 1010-1026
44. Youn H.D., Chatila T.A., and Liu J.O. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J. 19 (2000) 4323-4331
45. De Luca A., Severino A., De Paolis P., Cottone G., De Luca L., De Falco M., et al. p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor. Biochem. J. 369 (2003) 477-484
46. Creemers E.E., Sutherland L.B., Oh J., Barbosa A.C., and Olson E.N. Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR. Mol. Cell 23 (2006) 83-96
47. Pipes G.C., Creemers E.E., and Olson E.N. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 20 (2006) 1545-1556
48. Santelli E., and Richmond T.J. Crystal structure of MEF2A core bound to DNA at 1.5 Å resolution. J. Mol. Biol. 297 (2000) 437-449
49. Huang K., Louis J.M., Donaldson L., Lim F.L., Sharrocks A.D., and Clore G.M. Solution structure of the MEF2A-DNA complex: structural basis for the modulation of DNA bending and specificity by MADS-box transcription factors. EMBO J. 19 (2000) 2615-2628
50. Han A., He J., Wu Y., Liu J.O., and Chen L. Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2. J. Mol. Biol. 345 (2005) 91-102
51. Han A., Pan F., Stroud J.C., Youn H.D., Liu J.O., and Chen L. Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2. Nature 422 (2003) 730-734
52. Chen S.L., Dowhan D.H., Hosking B.M., and Muscat G.E. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes Dev. 14 (2000) 1209-1228
53. Blais A., Tsikitis M., Acosta-Alvear D., Sharan R., Kluger Y., and Dynlacht B.D. An initial blueprint for myogenic differentiation. Genes Dev. 19 (2005) 553-569
54. Meijsing S.H., Pufall M.A., So A.Y., Bates D.L., Chen L., and Yamamoto K.R. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324 (2009) 407-410
55. Sali A., and Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234 (1993) 779-815
56. Chen R., Li L., and Weng Z. ZDOCK: an initial-stage protein-docking algorithm. Proteins 52 (2003) 80-87
57. Wang L., Fan C., Topol S.E., Topol E.J., and Wang Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302 (2003) 1578-1581
58. Minor W., Tomchick D., and Otwinowski Z. Strategies for macromolecular synchrotron crystallography. Structure 8 (2000) R105-R110
59. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr., Sect. D: Biol. Crystallogr. 50 (1994) 760-776
60. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47 Pt 2 (1991) 110-119
61. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr., Sect. D: Biol. Crystallogr. 54 (1998) 905-921